Back to search
FDAFDA · Food and drugs·Recall number D-0172-2021

Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP), 0.5%, 150 mg per 30 mL (5 mg per mL), 30 mL Single Dose Vial (NDC 63323-462-01), packaged as 25 Single Dose Vials per tray (NDC 63323-462-37), Rx only, Fresenius Kabi, Lake Zurich, IL 60047.

Published December 30, 2020 · Recall initiated: December 10, 2020

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: Low out-of-specification assay results for the epinephrine component.

What to do

Voluntary: Firm initiated · Letter

Recall details

Brand
SENSORCAINE
Manufacturer
Fresenius Kabi USA, LLC
Distributor
Nationwide in the USA
Lot
Batch # 6123760, Exp 02/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card